Search Results

Los Angeles, CA. SAGE joins leading scientific associations and American universities in opposing the America COMPETES Reauthorization Act of 2015 (H.R. 1806). H.R.1806 challenges the value of the social and behavioral science research and restricts the proven processes of the experts at the National Science Foundation. SAGE opposes this legislation in its current form and urges members of Congress to vote no on H.R. 1806.

SAGE Publishing is pleased to partner with the Canadian Society of Plastic Surgeons to publish Plastic Surgery and Plastic Surgery Case Studies. The journals serve as major outlets for Canadian research, society guidelines, and continuing medical education.

London, UK - Much the same way individuals are encouraged to know their blood pressure and cholesterol numbers to maintain a healthy lifestyle, a new editorial in the Journal of Psychopharmacology urges the European public to know and monitor their alcohol intake number using a simple 10 point plan.

Los Angeles, CA - SAGE, the global independent scholarly and professional publisher, announced today the acquisition of The Goodwin Group International, LLC, publisher of MD Conference Express®, the first publication to subject medical conference highlights to the rigorous test of peer review.

The acquisition will strengthen SAGE’s ability to disseminate peer-reviewed content in medical disciplines and will complement SAGE’s current portfolio of more than 150 medical journals published on behalf of more than 100 medical societies.

Los Angeles, CA and London, UK. SAGE Publishing, one of the world’s leading independent and academic publishers, announces the selection of Atypon, the Silicon Valley-based publishing technology firm, to host all SAGE Journals content on Literatum, Atypon’s pioneering online publishing platform.

Welcoming the announcement, Bob Howard, Vice President Journals Editorial, said:

Marlborough, UK. Institutions across Canada can now benefit from full access to Frontier Life: Borderlands Settlement and Colonial Encounters, a digital collection of primary sources offering a glimpse into Canada’s unique historic past.

Los Angeles, CA - SAGE a leading independent academic and professional publisher today launched the Journal of Rehabilitation and Assistive Technologies Engineering (RATE), a peer reviewed, open access (OA) journal.RATE is an interdisciplinary journal focusing on the engineering aspects and their practical applications of rehabilitation and assistive technologies. It covers engineering design, electrical engineering, mechanical engineering, engineering devices and their applications, robotics and biomedical engineering. 

Los Angeles, CA. SAGE today announces that it will begin publishing Evolutionary Psychology an open access journal focused on the evolutionary origins of human behavior, beginning July, 2015.

Los Angeles, CA - SAGE today announces that it will begin publishing Annals of Otology, Rhinology & Laryngology (Annals), effective immediately. 

Los Angeles, CA - SAGE is delighted to announce the launch of a new, international open access journal for the qualitative study of nursing, Global Qualitative Nursing Research (GQNR). 

GQNR is a rigorously peer-reviewed open access journal that will publish qualitative research on topics important to nurses including nursing, care, health, and illness. Special sections of the journal will include ethics, methodological development, developing the theoretical base of nursing, establishing evidence, and application to practice.

Los Angeles, CA - SAGE announces today that it will begin publication of the bi-monthly journal, Technology in Cancer Research & Treatment (TCRT), currently published by Adenine Press of Schenectady, New York.

Los Angeles, CA - Cardiovascular disease is the leading causes of death worldwide and high cholesterol plays a major role in accelerating its progression. Medical practitioners have turned to statins as a treatment to decrease cholesterol-carrying lipoproteins such as small dense lipoproteins (sdLDL), considered to be especially harmful. A new study, out today in the Journal of Cardiovascular Pharmacology and Therapeutics finds that rosuvastatin may be more effective among prediabetic patients than patients with normal glucose levels.